|1||NCT00064129||Active, not recruiting||Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer||
||42||Male||18 Years and older (Adult, Senior)||NCT00064129||NCI-2009-00036
|May 13, 2003||January 10, 2011||July 9, 2003||December 13, 2017||
|2||NCT01363206||Unknown †||Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma||
||43||All||18 Years and older (Adult, Senior)||NCT01363206||GIPI
|GIPI||May 2011||May 2014||May 2015||June 1, 2011||March 10, 2014||
† Study has passed its completion date and status has not been verified in more than two years.